Actively Recruiting
Intravenous Dexamethasone Administration in Patients Undergoing Total Shoulder Arthroplasty
Led by Christian Candrian · Updated on 2026-03-05
74
Participants Needed
1
Research Sites
624 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The aim of the study is to evaluate if intravenous steroid supplementation can provide advantages over routine analgesia protocols in terms of post-operative symptoms (pain and nausea), length of hospital stay, shoulder range of motion, function and patient satisfaction
CONDITIONS
Official Title
Intravenous Dexamethasone Administration in Patients Undergoing Total Shoulder Arthroplasty
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients undergoing unilateral primary total anatomical or reverse shoulder arthroplasty (Total Shoulder Arthroplasty)
- Patients with a BMI >18.5 and <35
- Patients able to provide informed consent and follow all the study procedures as indicated by the protocol
- Informed Consent as documented by signature
You will not qualify if you...
- Contraindications to steroids
- Revision and post-traumatic TSA
- Active steroid or immunosuppressive therapy in the last 30 days before the operation
- Pregnant or breast-feeding women
- Presence of other clinically significant concomitant disease states (ASA IV)
- Uncontrolled diabetes mellitus
- Contraindications to Non-steroidal anti-inflammatory drugs
- Chronic systemic diseases as immunodeficiency, autoimmune disease (Systemic Lupus Erythematosus), gout, rheumatic arthritis
- Known or suspected non-compliance, drug or alcohol abuse
- Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia, etc. of the participant.
- Participation in another study with investigational drug within the 30 days preceding and during the present study
- Previous enrolment into the current study
- Enrolment of the investigator, his/her family members, employees and other dependent persons
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Christian Candrian
Lugano, Switzerland, 6900
Actively Recruiting
Research Team
C
Christian Candrian, Prof.Dr.med
CONTACT
G
Gyözö Lehoczky, Dr.med
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here